Work

The Novel BACE Inhibitor MK-8931 Dramatically Lowers CSF A Peptides in Healthy Subjects: Results from a Rising Single Dose Study (PL02.004)

Year: 2012

Type: conference-abstract

Source: Neurology

DOI: 10.1212/wnl.78.1_meetingabstracts.pl02.004

Authors: M. Forman, J. Tseng, J. Palcza, J. Leempoels, S. Ramael, G. Krishna, L. Ma, J. Wagner, M. Troyer

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), SGS (Belgium)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2014109882

Cites:

Cited by: 16

Related to: 10